Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZBH | Phantom Stock Units | Award | $0 | +500 | +3.17% | $0.00 | 16.3K | May 13, 2022 | Common Stock | 500 | $115.13 | Direct | F1, F2, F3, F4 |
transaction | ZBH | Restricted Stock Units | Award | $0 | +1.13K | +6.13% | $0.00 | 19.6K | May 13, 2022 | Common Stock | 1.13K | Direct | F2, F5, F6 |
Id | Content |
---|---|
F1 | The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. |
F2 | The Conversion or Exercise Price of Derivative Security is 1-for-1. |
F3 | These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. |
F4 | Includes 29.485 phantom stock units accrued on April 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
F5 | The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. |
F6 | Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Also reflects the adjustments that occurred as of March 1, 2022 in connection with the spinoff of ZimVie Inc. In connection with the spinoff, each then outstanding Restricted Stock Unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit. |